Similar Articles
1291 Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepatitis B virus cure
1292 Temporal trends of cirrhosis associated conditions
1293 Interventions to improve sarcopenia in cirrhosis: A systematic review
1294 Differential hepatic features presenting in Wilson disease-associated cirrhosis and hepatitis B-associated cirrhosis
1295 Exploratory metabolomics of metabolic syndrome: A status report
1296 Human antigen R mediated post-transcriptional regulation of inhibitors of apoptosis proteins in pancreatic cancer
1297 Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma
1298 Hepatitis C virus core protein modulates several signaling pathways involved in hepatocellular carcinoma
1299 Role of cenicriviroc in the management of nonalcoholic fatty liver disease
1300 Quality of life in patients with minimal hepatic encephalopathy
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA